Stockreport

Groundbreaking New FDA-Approved Drug for Acute Leukemia First Administered at Florida Cancer Specialists & Research Institute Sarasota Drug Development Unit [Yahoo! Finance]

HCA Healthcare, Inc.  (HCA) 
Last hca healthcare, inc. earnings: 4/21 08:30 am Check Earnings Report
US:NYSE Investor Relations: investor.hcahealthcare.com
PDF Food and Drug Administration (FDA) approved revumenib , a revolutionary drug for relapsed or refractory acute leukemia with a KMT2A translocation on November 15, 2024 . [Read more]